Domzalski David 4
4 · VYNE Therapeutics Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Tax Payment
Common Stock
2025-12-31$0.58/sh−12,684$7,358→ 416,208 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.